middle.news
How Mesoblast’s US$125M Credit Line Could Transform Its Growth Prospects
10:21am on Tuesday 30th of December, 2025 AEDT
•
Healthcare
Read Story
How Mesoblast’s US$125M Credit Line Could Transform Its Growth Prospects
10:21am on Tuesday 30th of December, 2025 AEDT
Key Points
Repayment of senior secured loan and partial subordinated royalty facility
New US$125 million credit line with fixed 8% interest rate and five-year interest-only period
Facility does not encumber Mesoblast’s material assets or intellectual property
No prepayment penalties or exit fees, enhancing financial flexibility
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mesoblast (ASX:MSB)
OPEN ARTICLE